The pharmaceutical landscape has seen significant changes over the past few decades, and one of the key trends reshaping this industry is the rise of branded generics. While generics themselves have been instrumental in making medications more affordable and accessible, branded generics are offering a new dimension to this concept by blending the benefits of both brand-name drugs and generics.
Branded generics have emerged as a strategic tool for pharmaceutical companies to navigate the challenges posed by the expiration of patents and the increasing demand for affordable healthcare. These products, while chemically identical to their generic counterparts, are marketed under a brand name and often come with added assurances regarding quality and trust.
What Are Branded Generics?
Branded generics are medicines that are identical in terms of their active ingredients, dosage form, strength, and intended use to the original branded drug but are marketed under a different name. These drugs typically enter the market after the patent of the original brand-name drug has expired. While they are chemically and therapeutically equivalent to the original product, they may be sold at a lower price and carry the brand name of the company manufacturing them, as opposed to being sold under the generic drug’s non-branded name.
Branded generics are gaining traction for several reasons, driven by the shifting dynamics of the global pharmaceutical market. Their increasing popularity is altering both the economic and marketing landscape of the pharmaceutical industry.
